Safety profile and hemodynamic responses to β-adrenergic stimulation by dobutamine in heart transplant patients

Chest

Volumn 116, Issue 6, 1999, Pages 1587-1592

  Akosah, Kwame O ^a   Denlinger, Bethany ^b   Mohanty, Pramod K ^b  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cardiac denervation; Dobutamine; Hemodynamic responses

Indexed keywords

DOBUTAMINE;

ADULT; ARTICLE; CHRONOTROPISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG SAFETY; DYSPNEA; HEADACHE; HEART ARRHYTHMIA; HEART DENERVATION; HEART MUSCLE OXYGEN CONSUMPTION; HEART PALPITATION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; VERTIGO;

EID: 0033401409     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.6.1587     Document Type: Article

References (35)

1. 1 Cohen J, Green TO, Ottenweller J, et al. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991; 67:1311-1318
2. 2 Coma-Canella I. Sensitivity and specificity of dobutamine electrocardiography test to detect multivessel disease after acute myocardial infarction. Eur Heart J 1990; 11:249-257
3. 3 Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83:1605-1614
4. 4 Mazeika PK, Nadazin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 1992; 19:1203-1211
5. 5 Martin T, Seaworthy JF, Johns JP, et al. Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med 1992; 116:190-196
6. 6 Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Circulation 1993; 88:15-19
7. 7 McNeil AJ, Fioretti PM, El-Said EM, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1991; 67:1131-1138
8. 8 Markowitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 1992; 69:1269-1273
9. 9 Tuttle RR, Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Cir Res 1975; 36:185-196
10. 10 Chartterjee K. Effects of dobutamine on coronary hemodynamic and myocardial energetics. In: Chartterjee K, ed. Dobutamine: a ten year review. New York, NY: NCM Publishers, 1989; 49-68
11. 11 Lavaller M, Amano J, Vatner SF, et al. Adverse effects of chronic cardiac denervation in conscious dogs with myocardial ischemia. Cir Res 1985; 57:383-392
12. 12 Vatner DE, Lavelle M, Amano J, et al. Mechanism of supersensitivity to sympathomimetic animals in the chronically denervated heart of the conscious dog. Cir Res 1985; 57:55-64
13. 13 Akosah KO, Mohanty PK, Funai JT, et al. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant 1994; 13:1024-1038
14. 14 Derumeaux G, Redonnet M, Schleifer DM, et al. Dobutamine stress echocardiography in orthotopic heart transplant recipients. J Am Coll Cardiol 1995; 25:1665-1672
15. 15 Spes CH, Mudra H, Schnaack SD, et al. Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound. Am J Cardiol 1996; 78:168-174
16. 16 Akosah KO, Olsovsky M, Kirchberg D, et al. Dobutamine stress echocardiography predicts cardiac events in heart transplant patients. Circulation 1996; 94(suppl II):II-283-II-288
17. 17 Lower RR, Kontos HA, Kosec JC, et al. Experiences in heart transplantation: technique, physiology and rejection. Am J Cardiol 1968; 22:766-775
18. 18 Armstrong WF, O'Donnell J, Ryan T, et al. Effect of prior myocardial infarction and extent and location of coronary disease on accuracy of exercise echocardiography. J Am Coll Cardiol 1987; 10:531-538
19. 19 Yusuf S, Theodoropoulos S, Dhalla N, et al. Influence of beta blockade on exercise capacity and heart rate response after human orthotopic and heterotopic cardiac transplantation. Am J Cardiol 1989; 64:636-641
20. 20 Quigg RJ, Rocco MB, Gauthier DF, et al. Mechanism of the attenuated peak heart rate response to exercise after orthotopic cardiac transplantation. J Am Coll Cardiol 1989; 14: 338-344
21. 21 Mohanty PK, Sowers JR, Thames MD, et al. Myocardial norepinephrine, epinephrine, and dopamine concentrations after cardiac transplantation. J Am Coll Cardiol 1986; 7:419-424
22. 22 Yusuf S, Theodoropoulos S, Mathias CJ, et al. Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade. Circulation 1987; 75:696-670
23. 23 Lurie KG, Bristow MR, Reitz BA. Increased B-adrenergic receptor density in an experimental model of cardiac transplantation. J Thorac Cardiovasc Surg 1983; 86:195-201
24. 24 Colucci WS, Alexander RW, Williams GH, et al. Decreased lymphocyte beta-adrenergic receptor density in patients with heart failure and tolerance to the beta adrenergic agonist pirbuterol. N Engl J Med 1981; 305:185-190
25. 25 Borow KM, Neumann A, Arensman FW, et al. Cardiac and peripheral vascular responses to adrenoceptor stimulation and blockade after cardiac transplantation. J Am Coll Cardiol 1989; 14:1229-1238
26. 26 Mohanty PK, Thames MD, Arrowood JA, et al. Impairment of cardiopulmonary baroreflex after cardiac transplantation in humans. Circulation 1987; 75: 914-921
27. 27 Bellet M, Cabrol C, Sussano P, et al. Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-aldosterone system. Am J Cardiol 1985; 56:927-931
28. 28 Levine TB, Olivari MT, Cohn JN. Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure. Am J Cardiol 1986; 58:1035-1040
29. 29 Akosah KO, Porter TR, Simon R, et al. Ischemia induced regional wall motion abnormality is improved after coronary angioplasty: demonstration by dobutamine stress echocardiography. J Am Coll Cardiol 1993; 21:584-589
30. 30 Akosah KO, Olsovsky M, Mohanty PK. Dobutamine stress induced angina in denervated cardiac transplant patients. Chest 1995; 108:695-700
31. 31 Akosah KO, Mohanty PK. Role of dobutamine stress echocardiography in heart transplant patients: a review. Chest 1998; 113:809-815
32. 32 Gao SZ, Alderman EL, Schroeder JS, et al. Accelerated coronary vascular disease in the heart transplant patients: coronary angiographic findings. J Am Coll Cardiol 1988; 12:334-340
33. 33 Bajaj S, Shah A, Crandall C, et al. Coronary collateral circulation in the transplanted heart. Circulation 1993; 88(part 2):263-269
34. 34 Lewis J, Selman SB, Murphy JD, et al. Dobutamine echocardiography for prediction of ischemic events in heart transplant patients. J Heart Lung Transplant 1997; 16:390-393
35. 35 Akosah KO, McDaniel S, Hanrahan JS, et al. Dobutamine stress echocardiography early after heart transplantation predicts development of allograft coronary artery disease and outcome J Am Coll Cardiol 1998; 31:1607-1614